5 results about "Co release" patented technology

The application discloses a fluorescent response type manganese carbonyl carbon monoxide releasing agent, a preparation method and application, wherein the compound has the following structural formula: the manganese carbonyl compound provided by the application has good photosensitivity and fluorescent characteristics, CO release can be accurately controlled through green light, the release process can be tracked in real time by using the change of the fluorescent intensity, and the manganese carbonyl compound is expected to be a photo-triggered carbon monoxide releasing agent with application prospect.

The invention provides a CO intelligent release platform based on a flexible implantable circuit and NFC induction. A forming method of the CO intelligent release platform comprises the following steps of constructing an NFC-LED module, forming a PDMS substrate, preparing a photosensitive composite layer, integrating devices and wirelessly activating a system. According to the CO intelligent release platform based on the flexible implantable circuit and NFC induction, a controllable CO release system based on a (carbon nitride / gold) composite nano-catalyst is constructed, and multiple mechanisms such as wireless NFC activation, blue light driving, nano-material directional reaction, release rate accurate regulation and control, targeted therapy and the like are combined; the defects of poor drug release accuracy, strong activation mode trauma, non-adjustable release rate, indefinite treatment window, high system energy consumption and the like in the prior art are overcome.

The invention specifically discloses a bionic nano platform as well as a preparation method and application thereof, and relates to the technical field of biological medicines. According to the bionic nano platform disclosed by the invention, efficient conversion from ultrasonic energy to chemical energy (CO release) is realized by constructing a Schottky heterojunction structure of Ni and LDH. In addition, by means of tumor cell membrane coating, homologous recognition characteristics are endowed to the nano-material, so that the nano-material can actively target brain glioma and penetrate through BBB, and precise delivery and deep tumor enrichment are achieved.

The present invention discloses a therapeutic system for the topic, transdermal and transcutaneous application of carbon monoxide (CO), comprising: (i) an adhesive layer, (ii) a gas-permeable and liquid- and solid-impermeable membrane, (iii) a reaction chamber comprising a CO releasing molecule A, and (iv) a gas-impermeable backing layer, wherein the transdermal therapeutic system is configured that the CO releasing molecule A can be brought into contact with a CO release triggering compound B in the reaction chamber (iii). The therapeutic system can be used for the treatment of wounds, inflammatory diseases of the skin, and inflammatory diseases of subcutaneous skin tissue, joints and tendons.

The application discloses a kind of low CO release amount reconstituted tobacco preparation methods based on catalysis-pore-forming synergistic system, which includes tobacco waste pretreatment, preparation mixed slurry and tobacco concentrate;Catalyst, pore-forming agent and dispersing agent are included in catalysis-pore-forming composite adjuvant;Slurry is mixed with inorganic filler and formed into a substrate;Composite adjuvant and concentrated liquid are coated and impregnated;Sectional gradient drying;Balance moisture, cut silk screening to get finished product.The application reduces the reconstituted tobacco CO release amount by 25.37%-28.42% through the synergistic effect of "catalysis+pore-forming", and the sensory comprehensive score is improved by 6.6-7.0 points, and does not need to transform existing production line, suitable for papermaking method mainstream process industrial production, which can be widely used in high-grade cigarette raw material preparation.